Keratoacanthoma, palmoplantar keratoderma developing in an advanced melanoma patient treated with vemurafenib regressed by blockade of mitogen-activated protein kinase kinase signaling.
about
Keratoacanthoma, palmoplantar keratoderma developing in an advanced melanoma patient treated with vemurafenib regressed by blockade of mitogen-activated protein kinase kinase signaling.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Keratoacanthoma, palmoplantar ...... otein kinase kinase signaling.
@en
Keratoacanthoma, palmoplantar ...... otein kinase kinase signaling.
@nl
type
label
Keratoacanthoma, palmoplantar ...... otein kinase kinase signaling.
@en
Keratoacanthoma, palmoplantar ...... otein kinase kinase signaling.
@nl
prefLabel
Keratoacanthoma, palmoplantar ...... otein kinase kinase signaling.
@en
Keratoacanthoma, palmoplantar ...... otein kinase kinase signaling.
@nl
P2093
P2860
P356
P1476
Keratoacanthoma, palmoplantar ...... rotein kinase kinase signaling
@en
P2093
Akira Hashimoto
Kayo Tanita
Sadanori Furudate
Setsuya Aiba
Takanori Hidaka
Yumi Kambayashi
P2860
P304
P356
10.1111/1346-8138.13898
P577
2017-04-25T00:00:00Z